000 | 00999 a2200301 4500 | ||
---|---|---|---|
005 | 20250514063339.0 | ||
264 | 0 | _c20030428 | |
008 | 200304s 0 0 eng d | ||
022 | _a1367-6733 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWright, J Fraser | |
245 | 0 | 0 |
_aRecombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector. _h[electronic resource] |
260 |
_bCurrent opinion in drug discovery & development _cMar 2003 |
||
300 |
_a174-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdenoviridae _xchemistry |
650 | 0 | 4 | _aAdsorption |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aGenetic Therapy _xmethods |
650 | 0 | 4 | _aGenetic Vectors |
650 | 0 | 4 | _aHumans |
700 | 1 | _aQu, Guang | |
700 | 1 | _aTang, Chunlin | |
700 | 1 | _aSommer, Jurg M | |
773 | 0 |
_tCurrent opinion in drug discovery & development _gvol. 6 _gno. 2 _gp. 174-8 |
|
999 |
_c12462559 _d12462559 |